Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will compare the interactions of a placebo and two FDA-approved sleeping
medications, Eszopiclone (Lunesta) and Zolpidem (Ambien), with certain chemical receptors in
the brain. We want to show that we can use positron emission tomography images to measure the
binding of these medications to the receptors.